Dhampur Bio — 360° view

Dhampur Bio, a company in the Sugar industry, reported revenue of ₹696 crore and net profit of ₹29 crore for the September 2026 quarter.

Dhampur Bio (NSE: DBOL) closed at ₹142.78 on 20 Nov 2026. Its market capitalisation is ₹948 crore and it trades at 37.1 times earnings.

Share price
₹142.78 (20 Nov 2026)
Market cap
₹948 Cr (20 Nov 2026)
P/E
37.07 (20 Nov 2026)
Revenue
₹696 Cr (September 2026 quarter)
Net profit
₹29 Cr (September 2026 quarter)
ROCE
4.98% (FY26)
ROE
2.61% (FY26)
Book value
₹162 (FY26)
Dividend yield
1.05% (last 12 months to 20 Nov 2026)
52-week high / low
₹153.99 / ₹97.01 (20 Nov 2026)
Sector
Fast Moving Consumer Goods
Industry
Sugar
Symbol
NSE: DBOL

Incorporated in 2022, Dhampur Bio Organics Ltd manufactures sugar, chemicals, ethanol, co-generation of power and other allied products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.